Literature DB >> 8905315

Use of enzyme-labelled protein G assay for the detection of anti Borrelia burgdorferi antibodies in wild animal sera.

D Deruaz1, P Eid, J Deruaz, A Sempéré, C Bourgouin, F Rodhain, C Pérez-Eid.   

Abstract

A modified ELISA was developed for the detection of anti-Borrelia burgdorferi (Bb) IgG antibodies in wild animal sera based on an Enzyme-Labelled-protein G Assay (ELGA). Microplates were coated with an extract of Bb sensu stricto strain (SVI) as antigen. Specific antibodies of the serum samples were detected by a peroxidase-labelled-protein G. Using comparative immunodiagnosis by means of a passive hemagglutination test (HA), ELGA was tested on 82 roe-deer blood samples. A correlation was found between the two methods (r = 0.66). Good reproducibility of titers was observed by ELGA technique. A minimal cross-reactivity was discovered with Leptospira. ELGA could facilitate the recognition of specific antibodies in collections of wild animal sera.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905315     DOI: 10.1007/bf00144006

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  17 in total

1.  Infection of Ixodes ricinus (Acari:Ixodidae) by Borrelia burgdorferi in Ile de France.

Authors:  E Zhioua; D Postic; F Rodhain; C Perez-Eid
Journal:  J Med Entomol       Date:  1996-07       Impact factor: 2.278

2.  A physicochemical study of protein G, a molecule with unique immunoglobulin G-binding properties.

Authors:  B Akerström; L Björck
Journal:  J Biol Chem       Date:  1986-08-05       Impact factor: 5.157

Review 3.  Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci.

Authors:  J J Langone
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

4.  Streptococcal protein G, expressed by streptococci or by Escherichia coli, has separate binding sites for human albumin and IgG.

Authors:  L Björck; W Kastern; G Lindahl; K Widebäck
Journal:  Mol Immunol       Date:  1987-10       Impact factor: 4.407

5.  Antibody response in white-footed mice (Peromyscus leucopus) experimentally infected with the Lyme disease spirochete (Borrelia burgdorferi).

Authors:  T G Schwan; K K Kime; M E Schrumpf; J E Coe; W J Simpson
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

6.  Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease.

Authors:  L A Magnarelli; J M Meegan; J F Anderson; W A Chappell
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

7.  Borrelia infections of ruminants in Europe.

Authors:  G Uilenberg; H K Hinaidy; N M Perié; T Feenstra
Journal:  Vet Q       Date:  1988-01       Impact factor: 3.320

8.  Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.

Authors:  G Baranton; D Postic; I Saint Girons; P Boerlin; J C Piffaretti; M Assous; P A Grimont
Journal:  Int J Syst Bacteriol       Date:  1992-07

9.  Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies.

Authors:  B Akerström; T Brodin; K Reis; L Björck
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

10.  Isolation and cultivation of Lyme disease spirochetes.

Authors:  A G Barbour
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  2 in total

1.  Detection of spirochaetes of Borrelia burgdorferi complexe in the skin of cervids by PCR and culture.

Authors:  B Pichon; B Gilot; C Pérez-Eid; P Bruno; G Bruno; P E Claudine
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Serological signature of tick-borne pathogens in Scandinavian brown bears over two decades.

Authors:  Lye Paillard; Krista L Jones; Alina L Evans; Jérémy Berret; Maxime Jacquet; Reto Lienhard; Mahmoud Bouzelboudjen; Jon M Arnemo; Jon E Swenson; Maarten J Voordouw
Journal:  Parasit Vectors       Date:  2015-07-28       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.